Alternatives to MEDPNC
MEDPNC is a Drug Therapy tool: predicting personalized drug combinations for cancer patients based on altered protein networks. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Drug Therapy companies to MEDPNC
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
Nucleai63HealthcareTel Aviv, Israel$58.5MAI-powered spatial biology platform for precision medicine and drug development.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website
Imagene62HealthcareTel Aviv, Israel$44.5MAI-powered platform for profiling cancer biomarkers from digitized biopsy images.
- Website
Insitro62HealthcareSouth San Francisco, United States$243.0MData-driven drug discovery and development company using machine learning and high-throughput biology.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
TrialJectory58HealthcareNew York, United States$39.7MAI-powered platform connecting cancer patients to advanced treatments and clinical trials.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
NeuroKaire56NeuroscienceTel Aviv, Israel$27.3MPersonalized medical testing tool to optimize drug therapy for depression.
- Website
FORE Biotherapeutics56HealthcarePhiladelphia, United States$232.4MPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
- Website
Pangea Biomed55HealthcareTel Aviv, Israel$12.0MBiotech company using AI and deep RNA analysis to predict cancer treatment response.
- Website
Curesponse55Life SciencesTel Aviv, Israel$28.0MPersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
- Website
JaxBio55Life SciencesSan Francisco, United States$21.7MAI-powered blood test for early cancer detection and subtyping.
- Website
Geneyx Genomex55HealthcareTel Aviv, Israel$10.0MHarnessing genetic data for digital insights in rare and germline disorders.
- Website
Oncohost54HealthcareTel Aviv, Israel$43.0MLeveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.
- Website
Senseera54HealthcareSan Diego, United States$7.1MDeveloping a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.
- Website
SpotitEarly53HealthcareTel Aviv, Israel$6.2MScent-based multi-cancer early detection screening test using AI and bio-detectors.
- Website
Syantra53BiotechCalgary, Canada$3.6MA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
Showing the 20 closest matches. See the rest on the MEDPNC profile.
Compare MEDPNC head to head
Side by side on what each one does, what it costs, and what real users report.